BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2022 9:44:44 AM | Browse: 460 | Download: 1655
 |
Received |
|
2022-08-07 12:36 |
|
Peer-Review Started |
|
2022-08-07 12:38 |
|
First Decision by Editorial Office Director |
|
2022-09-25 10:34 |
|
Return for Revision |
|
2022-09-25 10:34 |
|
Revised |
|
2022-10-04 08:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-10-24 03:20 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-10-24 08:49 |
|
Articles in Press |
|
2022-10-24 08:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-10-31 01:07 |
|
Publish the Manuscript Online |
|
2022-11-23 09:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Xiang Zhong and Xi-Feng Wei |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Xiang Zhong, MA, Attending Doctor, Surgeon, Department of Thoracic Surgery, First Affiliated Hospital of Gannan Medical University, No 128 Jinling West Road, Ganzhou 341000, Jiangxi Province, China. bronco067@126.com |
| Key Words |
Lung adenocarcinoma; Epidermal growth factor receptor mutation; Anaplastic lymphoma kinase rearrangement; Co-mutation; Tyrosine kinase inhibitor |
| Core Tip |
This study retrospectively analyzed the clinicopathological features of patients with co-mutations of EGFR and ALK genes in lung adenocarcinoma, and collected follow-up data of these patients, especially focusing on the tyrosine kinase inhibitors (TKIs) selected and its therapeutic effect in the real world from a single institute experience. The results showed that the positive rate of lung adenocarcinoma patients with co-mutations of EGFR and ALK genes, which were more common in women, non-smoking and stage IV patients with bone metastasis, was relatively high in Gannan region, which may be related to regional heterogeneity. EGFR-TKIs were their preferred drugs for targeted therapy in these patients, but the therapeutic effect is not good. EGFR/ALK dual-TKIs may be more effective targeted drugs. |
| Publish Date |
2022-11-23 09:44 |
| Citation |
Zhong WX, Wei XF. Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study. World J Clin Cases 2022; 10(33): 12164-12174
|
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i33/12164.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i33.12164 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
